Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Abstract 304: Micronuclei in circulating stromal cells correlates with PD-L1 expression and predicts progression in metastatic breast cancer

Dimpal M. Kasabwala, Massimo Cristofanilli, R. Katherine Alpaugh, Saranya Chumsri, Carolina Reduzzi, Cha-Mei Tang, Rena G. Lapidus, Giuseppe Del Priore, William V. Williams, Daniel L. Adams

Cancer Res (2023) 83 (7_Supplement): 304.

https://doi.org/10.1158/1538-7445.AM2023-304

Published: 04 April 2023

View articletitled, Abstract 304: Micronuclei in circulating stromal cells correlates with PD-L1 expression and predicts progression in metastatic breast cancer

Journal Articles

Abstract 2310: Tumor macrophage fusion cells detected in the circulation of metastatic breast cancer patients is prognostic for rapid progression and death

Daniel L. Adams, R. Katherine Alpaugh, Rena G. Lapidus, Saranya Chumsri, Carolina Reduzzi, Kirby P. Gardner, Cha-Mei Tang, Giuseppe Del Priore, William V. Williams, Massimo Cristofanilli

Cancer Res (2023) 83 (7_Supplement): 2310.

https://doi.org/10.1158/1538-7445.AM2023-2310

Published: 04 April 2023

View articletitled, Abstract 2310: Tumor macrophage fusion cells detected in the circulation of metastatic breast cancer patients is prognostic for rapid progression and death

Journal Articles

Abstract 1428: PARP inhibitor resensitizes TKI-resistant AML to TKI

Anna J. Dellomo, Rena G. Lapidus, Mariusz Karbowski, Maria R. Baer, Tami J. Kingsbury, Feyruz V. Rassool

Cancer Res (2021) 81 (13_Supplement): 1428.

https://doi.org/10.1158/1538-7445.AM2021-1428

Published: 01 July 2021

View articletitled, Abstract 1428: PARP inhibitor resensitizes TKI-resistant AML to TKI

Journal Articles

Abstract 4047: Pegcrisantaspase-based combination therapies for the treatment of pancreatic adenocarcinoma

Dominique Bollino, Sophie Nerone, Xinrong Ma, Kayla M. Tighe, Brandon Carter-Cooper, Rena G. Lapidus, Ashkan Emadi

Cancer Res (2020) 80 (16_Supplement): 4047.

https://doi.org/10.1158/1538-7445.AM2020-4047

Published: 15 August 2020

View articletitled, Abstract 4047: Pegcrisantaspase-based combination therapies for the treatment of pancreatic adenocarcinoma

Journal Articles

Abstract 542: Anti-CD19 therapy for precursor B-acute lymphoblastic leukemia: Response and resistance mechanisms

Firas El Chaer, Brandon Carter-Cooper, Rena G. Lapidus, Maria R. Baer, Zeba N. Singh, Ashkan Emadi

Cancer Res (2019) 79 (13_Supplement): 542.

https://doi.org/10.1158/1538-7445.AM2019-542

Published: 01 July 2019

View articletitled, Abstract 542: Anti-CD19 therapy for precursor B-acute lymphoblastic leukemia: Response and resistance mechanisms

Journal Articles

Abstract 884: Mechanistically-driven investigation of pegcrisantaspase combination therapy against acute myeloid leukemia

Hannah Kaizer, Binny Bhandary, Brandon A. Carter-Cooper, Eun Yong Choi, Bandish Kapadia, Elizabeth T. Chang, Rena G. Lapidus, Ronald B. Gartenhaus, Ashkan Emadi

Cancer Res (2018) 78 (13_Supplement): 884.

https://doi.org/10.1158/1538-7445.AM2018-884

Published: 01 July 2018

View articletitled, Abstract 884: Mechanistically-driven investigation of pegcrisantaspase combination therapy against acute myeloid leukemia

Journal Articles

Abstract 2948: Combination treatment of PARP inhibitor, BMN 673 and DNMT inhibitor, Azacytidine: A potential therapy for BRCA negative and positive, triple negative breast cancers

Khadiza Chowdhury, Rena G. Lapidus, Eun Yong Choi, Stephen Baylin, Feyruz V. Rassool

Cancer Res (2015) 75 (15_Supplement): 2948.

https://doi.org/10.1158/1538-7445.AM2015-2948

Published: 01 August 2015

View articletitled, Abstract 2948: Combination treatment of PARP inhibitor, BMN 673 and DNMT inhibitor, Azacytidine: A potential therapy for BRCA negative and positive, triple negative breast cancers

Journal Articles

Abstract 3268: Targeting leukemia metabolism: augmentation of anti-leukemic activity of arsenic trioxide (As₂O₃) against non-APL AML cell lines in presence of dichloroacetate (DCA).

Ashkan Emadi, Mariola Sadowska, Brandon A. Carter-Cooper, Rena G. Lapidus, Edward A. Sausville

Cancer Res (2013) 73 (8_Supplement): 3268.

https://doi.org/10.1158/1538-7445.AM2013-3268

Published: 15 April 2013

View articletitled, Abstract 3268: Targeting leukemia metabolism: augmentation of anti-leukemic activity of arsenic trioxide (As2O3) against non-APL AML cell lines in presence of dichloroacetate (DCA).

Journal Articles

Comparison of Neuropathy-Inducing Effects of Eribulin Mesylate, Paclitaxel, and Ixabepilone in Mice

Krystyna M. Wozniak, Kenichi Nomoto, Rena G. Lapidus, Ying Wu, Valentina Carozzi, Guido Cavaletti, Kazuhiro Hayakawa, Satoru Hosokawa, Murray J. Towle, Bruce A. Littlefield, Barbara S. Slusher

Cancer Res (2011) 71 (11): 3952–3962.

https://doi.org/10.1158/0008-5472.CAN-10-4184

Published: 31 May 2011

View articletitled, Comparison of Neuropathy-Inducing Effects of Eribulin Mesylate, Paclitaxel, and Ixabepilone in Mice

Includes: Supplementary data

Journal Articles

Abstract 4438: Comparison of neuropathy-inducing effects of eribulin versus paclitaxel in mice

Krystyna M. Wozniak, Rena G. Lapidus, Ying Wu, Valentina Carozzi, Guido Cavalleti, Kazuhiro Hayakawa, Satoru Hosokawa, Murray J. Towle, Bruce A. Littlefield, Kenichi Nomoto, Barbara S. Slusher

Cancer Res (2010) 70 (8_Supplement): 4438.

https://doi.org/10.1158/1538-7445.AM10-4438

Published: 15 April 2010

View articletitled, Abstract 4438: Comparison of neuropathy-inducing effects of eribulin versus paclitaxel in mice

Journal Articles

2-MPPA, a selective inhibitor of GCPII (NAALADase/PSMA), attenuates chemotherapy-induced neuropathy in mice

Zhaocheng Tang, Rena G. Lapidus, Krystyna M. Wozniak, Barbara S. Slusher

Cancer Res (2006) 66 (8_Supplement): 464.

Published: 15 April 2006

View articletitled, 2-MPPA, a selective inhibitor of GCPII (NAALADase/PSMA), attenuates chemotherapy-induced neuropathy in mice

Journal Articles

Oral administration of poly(ADP-ribose) polymerase inhibitor prevents intestinal damage induced by irinotecan and enhances the efficacy of irinotecan and temozolomide combination against colon carcinoma

Jie Zhang, Lucio Tentori, Carlo Leonetti, Marco Scarsella, Alessia Muzi, Emanuela Mazzon, Matteo Vergati, Olindo Forini, Rena G. Lapidus, Weizheng Xu, Salvatore Cuzzocrea, Grazia Graziani

Cancer Res (2006) 66 (8_Supplement): 574.

Published: 15 April 2006

View articletitled, Oral administration of poly(ADP-ribose) polymerase inhibitor prevents intestinal damage induced by irinotecan and enhances the efficacy of irinotecan and temozolomide combination against colon carcinoma

Journal Articles

PARP inhibitors enhance the effect of cisplatin against tumors and ameliorate cisplatin-induced neuropathy

Rena G. Lapidus, Weizheng Xu, Eric Spicer, Randall Hoover, Jie Zhang

Cancer Res (2006) 66 (8_Supplement): 506.

Published: 15 April 2006

View articletitled, PARP inhibitors enhance the effect of cisplatin against tumors and ameliorate cisplatin-induced neuropathy

Journal Articles

2-MPPA, a selective inhibitor of Prostate Specific Membrane Antigen (PSMA), attenuates taxol-induced neuropathy in mice

Zhaocheng Tang, Rena G. Lapidus, Krystyna M. Wozniak, Howard I. Scher, Barbara S. Slusher

Cancer Res (2005) 65 (9_Supplement): 991.

Published: 01 May 2005

View articletitled, 2-MPPA, a selective inhibitor of Prostate Specific Membrane Antigen (PSMA), attenuates taxol-induced neuropathy in mice

Journal Articles

Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of irinotecan against colon carcinomas

Lucio Tentori, Carlo Leonetti, Marco Scarsella, Matteo Vergati, Allessia Muzi, Weizhing Xu, Rena G. Lapidus, Jie Zhang, Grazia Graziani

Cancer Res (2005) 65 (9_Supplement): 603–604.

Published: 01 May 2005

View articletitled, Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of irinotecan against colon carcinomas

Journal Articles

Multimodality imaging with a low-molecular weight ligand Targeting prostate specific membrane antigen

Valerie Humblet, Takashi Tsukamoto, Larry R. Williams, Rena G. Lapidus, Barbara S. Slusher, John V. Frangioni

Cancer Res (2005) 65 (9_Supplement): 902.

Published: 01 May 2005

View articletitled, Multimodality imaging with a low-molecular weight ligand Targeting prostate specific membrane antigen

Journal Articles

Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of temozolomide against melanoma growing at the CNS site.

Lucio Tentori, Carlo Leonetti, Marco Scarsella, Weizheng Xu, David C. Calvin, Lisa Morgan, Zhaocheng Tang, Krystyna M. Wozniak, Christina Alemu, Randall Hoover, Rena G. Lapidus, Gabriella Zupi, Jie Zhang, Grazia Graziani

Cancer Res (2004) 64 (7_Supplement): 462.

Published: 01 April 2004

View articletitled, Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of temozolomide against melanoma growing at the CNS site.

Journal Articles

GPI 15427, a PARP inhibitor, enhances radiation treatment in a human xenograft head and neck model

Guayan Li, Xin Li, Jie Zhang, Weizheng Xu, David C. Calvin, Lisa Morgan, Zhaocheng Tang, Krystyna Wozniak, Christina Alemu, Randall Hoover, Bert W. O’Malley, Jr., Rena G. Lapidus, Daqing Li

Cancer Res (2004) 64 (7_Supplement): 311.

Published: 01 April 2004

View articletitled, GPI 15427, a PARP inhibitor, enhances radiation treatment in a human xenograft head and neck model

Journal Articles

Mapping of ER Gene CpG Island Methylation by Methylation-specific Polymerase Chain Reaction

Rena G. Lapidus, Sharyl J. Nass, Kimberly A. Butash, Fritz F. Parl, Sigmund A. Weitzman, Jeremy G. Graff, James G. Herman, Nancy E. Davidson

Cancer Res (1998) 58 (12): 2515–2519.

Published: 01 June 1998

View articletitled, Mapping of ER Gene CpG Island Methylation by Methylation-specific Polymerase Chain Reaction

Journal Articles

E-Cadherin Expression Is Silenced by DNA Hypermethylation in Human Breast and Prostate Carcinomas

Jeremy R. Graff, James G. Herman, Rena G. Lapidus, Hemi Chopra, Rosa Xu, David F. Jarrard, William B. Isaacs, Paula M. Pitha, Nancy E. Davidson, Stephen B. Baylin

Cancer Res (1995) 55 (22): 5195–5199.

Published: 01 November 1995

View articletitled, E-Cadherin Expression Is Silenced by DNA Hypermethylation in Human Breast and Prostate Carcinomas

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 304: Micronuclei in circulating stromal cells correlates with PD-L1 expression and predicts progression in metastatic breast cancer

Abstract 2310: Tumor macrophage fusion cells detected in the circulation of metastatic breast cancer patients is prognostic for rapid progression and death

Abstract 1428: PARP inhibitor resensitizes TKI-resistant AML to TKI

Abstract 4047: Pegcrisantaspase-based combination therapies for the treatment of pancreatic adenocarcinoma

Abstract 542: Anti-CD19 therapy for precursor B-acute lymphoblastic leukemia: Response and resistance mechanisms

Abstract 884: Mechanistically-driven investigation of pegcrisantaspase combination therapy against acute myeloid leukemia

Abstract 2948: Combination treatment of PARP inhibitor, BMN 673 and DNMT inhibitor, Azacytidine: A potential therapy for BRCA negative and positive, triple negative breast cancers

Abstract 3268: Targeting leukemia metabolism: augmentation of anti-leukemic activity of arsenic trioxide (As₂O₃) against non-APL AML cell lines in presence of dichloroacetate (DCA).

Comparison of Neuropathy-Inducing Effects of Eribulin Mesylate, Paclitaxel, and Ixabepilone in Mice

Abstract 4438: Comparison of neuropathy-inducing effects of eribulin versus paclitaxel in mice

2-MPPA, a selective inhibitor of GCPII (NAALADase/PSMA), attenuates chemotherapy-induced neuropathy in mice

Oral administration of poly(ADP-ribose) polymerase inhibitor prevents intestinal damage induced by irinotecan and enhances the efficacy of irinotecan and temozolomide combination against colon carcinoma

PARP inhibitors enhance the effect of cisplatin against tumors and ameliorate cisplatin-induced neuropathy

2-MPPA, a selective inhibitor of Prostate Specific Membrane Antigen (PSMA), attenuates taxol-induced neuropathy in mice

Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of irinotecan against colon carcinomas

Multimodality imaging with a low-molecular weight ligand Targeting prostate specific membrane antigen

Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of temozolomide against melanoma growing at the CNS site.

GPI 15427, a PARP inhibitor, enhances radiation treatment in a human xenograft head and neck model

Mapping of ER Gene CpG Island Methylation by Methylation-specific Polymerase Chain Reaction

E-Cadherin Expression Is Silenced by DNA Hypermethylation in Human Breast and Prostate Carcinomas

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only